YIH
GUTS icon

Y-Intercept (HK)’s Fractyl Health GUTS Stock Holding History

Y-Intercept (HK)’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-111,425
Closed -$181K – 2128
2025
Q2 		$181K Buy
+111,425
New +$180K ﹤0.01% 1478

Other funds holding GUTS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
CCM
Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Y-Intercept (HK)'s GUTS Position: Q3 2025 in Review

Y-Intercept (HK) sold out of Fractyl Health (GUTS) in Q3 2025, closing a stake of 111,425 shares — an estimated $181K sold.

Y-Intercept (HK) first reported a position in GUTS in Q2 2025 and held it in 1 quarter. The position peaked at $181K in Q2 2025. 74 funds tracked by Wall St. Rank hold GUTS as of Q3 2025.

  • Y-Intercept (HK) reported no remaining Fractyl Health position as of Q3 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 111,425 Fractyl Health shares in Q3 2025, an estimated $181K.
  • Y-Intercept (HK) first reported a position in Fractyl Health in Q2 2025 and held it in 1 quarter.
  • Y-Intercept (HK)'s Fractyl Health position peaked at $181K in Q2 2025.
  • 74 funds tracked by Wall St. Rank held Fractyl Health as of Q3 2025.

Based on Y-Intercept (HK)'s 13F filing for Q3 2025, filed 31 Oct 2025.